Tredje Ap Fonden Abbott Laboratories Transaction History

Tredje Ap Fonden

$10.8 Billion
Q3 2024

A detailed history of Tredje Ap Fonden transactions in Abbott Laboratories stock. As of the latest transaction made, Tredje Ap Fonden holds 721,486 shares of ABT stock, worth $84.3 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

721,486

Previous 730,664 1.26%

Holding current value

$84.3 Million

Previous $75.9 Million 8.34%

% of portfolio

0.76%

Previous 0.74%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $918,442 - $1.08 Million	-9,178 Reduced 1.26%	721,486 $82.3 Million
Q2 2024 Aug 12, 2024	BUY	$100.73 - $112.44 $4.23 Million - $4.72 Million	42,000 Added 6.1%	730,664 $75.9 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $5.48 Million - $6.05 Million	50,000 Added 7.83%	688,664 $78.3 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $4.45 Million - $5.45 Million	49,380 Added 8.38%	638,664 $70.3 Million
Q3 2023 Nov 09, 2023	BUY	$95.53 - $114.62 $246,371 - $295,604	2,579 Added 0.44%	589,284 $57.1 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $3.37 Million - $3.76 Million	33,488 Added 6.05%	586,705 $64 Million
Q1 2023 May 10, 2023	BUY	$96.86 - $114.01 $1.56 Million - $1.83 Million	16,064 Added 2.99%	553,217 $56 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $12.6 Million - $14.8 Million	132,949 Added 32.89%	537,153 $59 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $14.3 Million - $16.5 Million	147,374 Added 57.38%	404,204 $39.1 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $1.14 Million - $1.39 Million	10,000 Added 4.05%	256,830 $30.4 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $1.35 Million - $1.66 Million	-11,728 Reduced 4.54%	246,830 $34.7 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $1.63 Million - $1.81 Million	14,000 Added 5.72%	258,558 $30.5 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $1.59 Million - $1.87 Million	15,000 Added 6.53%	244,558 $28.4 Million
Q2 2020 Aug 11, 2020	SELL	$76.57 - $98.0 $5.19 Million - $6.64 Million	-67,778 Reduced 22.8%	229,558 $21 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $3.9 Million - $5.71 Million	62,143 Added 26.42%	297,336 $22 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $1.66 Million - $1.85 Million	-21,131 Reduced 8.24%	235,193 $20.4 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $173,091 - $187,685	2,115 Added 0.83%	256,324 $21.4 Million
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $72,734 - $84,830	-998 Reduced 0.39%	254,209 $21.4 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $500,888 - $605,573	7,564 Added 3.05%	255,207 $20.4 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $6.86 Million - $7.77 Million	-104,622 Reduced 29.7%	247,643 $17.9 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $5.02 Million - $6.06 Million	-82,565 Reduced 18.99%	352,265 $25.8 Million
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $623,252 - $687,884	-10,826 Reduced 2.43%	434,830 $26.5 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $405,369 - $458,318	7,204 Added 1.64%	445,656 $26.7 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $3.09 Million - $3.31 Million	57,510 Added 15.1%	438,452 $25 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $18.3 Million - $20.4 Million	380,942	380,942 $20.3 Million

Others Institutions Holding ABT

# of Institutions

3,198

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tredje Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Tredje Ap Fonden with notifications on news.

Account